Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Regulatory News: Medincell (Paris:MEDCL): Évènement Date Résultats annuels 2024-2025 (avril 2024-mars 2025) mardi 17 juin 2025 Assemblée Générale...
Article 223-16 du règlement Général de l’Autorité des Marchés Financiers Regulatory News: MedinCell (Paris:MEDCL) : Place de cotation : Euronext...
Regulatory News: Medincell (Paris:MEDCL) joins the Euronext SBF 120 index, which includes the 120 largest companies listed on Euronext Paris...
Medincell (Paris:MEDCL) joins the Euronext SBF 120 index, which includes the 120 largest companies listed on Euronext Paris, including the CAC 40...
(April 1st, 2024 - September 30, 2024) Regulatory News: Medincell (Paris:MEDCL): Key highlights Sales growth of UZEDY® in the United States €2.8...
Analysis of a major subgroup of patients undergoing a first Total Knee Replacement (TKR), representing over 70% of the trial population (108 out...
Regulatory News: Medincell (Paris:MEDCL): Analysis of a major subgroup of patients undergoing a first Total Knee Replacement (TKR), representing...
Regulatory News: Medincell (Paris:MEDCL) tiendra une vidéoconférence le mardi 10 décembre 2024 pour présenter les résultats financiers...
ACCESS HERE THE COMPLETE PRESS RELEASE Medincell’s (Paris:MEDCL) partner Teva Pharmaceuticals shared today as part of its Q3 2024 results, the...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관